HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
Valeri
M
M
Clinica Chirurgica, Università Tor Vergata, Rome, Italy.
Piazza
A
A
Torlone
N
N
Poggi
E
E
Monaco
P I
PI
Provenzani
L
L
Adorno
D
D
Casciani
C U
CU
D000918:Antibody Specificity / Q000276:immunology*; D000961:Antilymphocyte Serum / Q000032:analysis; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007518:Isoantibodies / Q000032:analysis*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000276:immunology*; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D006684:HLA-DR Antigens; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D007518:Isoantibodies